 | • レポートコード：D005-00792 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、パーキンソン病治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。パーキンソン病治療の種類別市場規模（ドーパミン作動薬、レボドパ、グルタミン酸拮抗薬、アポモルヒネ、COMT阻害剤、抗コリン作用薬、MAO-B阻害剤、その他の薬物）、用途別市場規模（病院、医療機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Bausch Health、Teva、Merck、Abbvie、Novartis、Sun Pharma、Impax、Boehringer Ingelheim、Lundbeck、Wockhardt、Acadia、UCB ・地域別グローバル市場分析 2015年-2020年 ・パーキンソン病治療の北米市場（アメリカ、カナダ、メキシコ） ・パーキンソン病治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・パーキンソン病治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・パーキンソン病治療の南米市場（ブラジル、アルゼンチン） ・パーキンソン病治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ドーパミン作動薬、レボドパ、グルタミン酸拮抗薬、アポモルヒネ、COMT阻害剤、抗コリン作用薬、MAO-B阻害剤、その他の薬物 ・用途別分析：病院、医療機関、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Parkinson’s Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Parkinson’s Disease Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Parkinson’s Disease Treatments market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Parkinson’s Disease Treatments market has been segmented into:
Dopamine Agonists
Levodopa
Glutamate Antagonist
Apomorphine
COMT Inhibitors Anticholinergics
MAO-B Inhibitors
Other Drugs
By Application, Parkinson’s Disease Treatments has been segmented into:
Hospitals
Healthcare Institutes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Parkinson’s Disease Treatments market presented in the report. This section sheds light on the sales growth of different regional and country-level Parkinson’s Disease Treatments markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Parkinson’s Disease Treatments market.
The report offers in-depth assessment of the growth and other aspects of the Parkinson’s Disease Treatments market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Parkinson’s Disease Treatments Market Share Analysis
Parkinson’s Disease Treatments competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Parkinson’s Disease Treatments sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Parkinson’s Disease Treatments sales, revenue and market share for each player covered in this report.
The major players covered in Parkinson’s Disease Treatments are:
GSK
Bausch Health
Teva
Merck
Abbvie
Novartis
Sun Pharma
Impax
Boehringer Ingelheim
Lundbeck
Wockhardt
Acadia
UCB
Table of Contents
1 Parkinson’s Disease Treatments Market Overview
1.1 Product Overview and Scope of Parkinson’s Disease Treatments
1.2 Classification of Parkinson’s Disease Treatments by Type
1.2.1 Global Parkinson’s Disease Treatments Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Parkinson’s Disease Treatments Revenue Market Share by Type in 2019
1.2.3 Dopamine Agonists
1.2.4 Levodopa
1.2.5 Glutamate Antagonist
1.2.6 Apomorphine
1.2.7 COMT Inhibitors Anticholinergics
1.2.8 MAO-B Inhibitors
1.2.9 Other Drugs
1.3 Global Parkinson’s Disease Treatments Market by Application
1.3.1 Overview: Global Parkinson’s Disease Treatments Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Healthcare Institutes
1.3.4 Others
1.4 Global Parkinson’s Disease Treatments Market by Regions
1.4.1 Global Parkinson’s Disease Treatments Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Parkinson’s Disease Treatments (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Parkinson’s Disease Treatments Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Parkinson’s Disease Treatments Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson’s Disease Treatments Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Parkinson’s Disease Treatments Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson’s Disease Treatments Status and Prospect (2015-2025)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bausch Health
2.2.1 Bausch Health Details
2.2.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bausch Health SWOT Analysis
2.2.4 Bausch Health Product and Services
2.2.5 Bausch Health Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva SWOT Analysis
2.3.4 Teva Product and Services
2.3.5 Teva Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbvie SWOT Analysis
2.5.4 Abbvie Product and Services
2.5.5 Abbvie Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sun Pharma
2.7.1 Sun Pharma Details
2.7.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sun Pharma SWOT Analysis
2.7.4 Sun Pharma Product and Services
2.7.5 Sun Pharma Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.8 Impax
2.8.1 Impax Details
2.8.2 Impax Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Impax SWOT Analysis
2.8.4 Impax Product and Services
2.8.5 Impax Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.10 Lundbeck
2.10.1 Lundbeck Details
2.10.2 Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Lundbeck SWOT Analysis
2.10.4 Lundbeck Product and Services
2.10.5 Lundbeck Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.11 Wockhardt
2.11.1 Wockhardt Details
2.11.2 Wockhardt Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Wockhardt SWOT Analysis
2.11.4 Wockhardt Product and Services
2.11.5 Wockhardt Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.12 Acadia
2.12.1 Acadia Details
2.12.2 Acadia Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Acadia SWOT Analysis
2.12.4 Acadia Product and Services
2.12.5 Acadia Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.13 UCB
2.13.1 UCB Details
2.13.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 UCB SWOT Analysis
2.13.4 UCB Product and Services
2.13.5 UCB Parkinson’s Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Parkinson’s Disease Treatments Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson’s Disease Treatments Players Market Share
3.2.2 Top 10 Parkinson’s Disease Treatments Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Parkinson’s Disease Treatments Revenue and Market Share by Regions
4.2 North America Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
4.3 Europe Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
4.5 South America Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
5 North America Parkinson’s Disease Treatments Revenue by Countries
5.1 North America Parkinson’s Disease Treatments Revenue by Countries (2015-2020)
5.2 USA Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
5.3 Canada Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
5.4 Mexico Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
6 Europe Parkinson’s Disease Treatments Revenue by Countries
6.1 Europe Parkinson’s Disease Treatments Revenue by Countries (2015-2020)
6.2 Germany Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
6.3 UK Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
6.4 France Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
6.5 Russia Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
6.6 Italy Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Parkinson’s Disease Treatments Revenue by Countries
7.1 Asia-Pacific Parkinson’s Disease Treatments Revenue by Countries (2015-2020)
7.2 China Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
7.3 Japan Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
7.4 Korea Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
7.5 India Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
8 South America Parkinson’s Disease Treatments Revenue by Countries
8.1 South America Parkinson’s Disease Treatments Revenue by Countries (2015-2020)
8.2 Brazil Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
8.3 Argentina Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Parkinson’s Disease Treatments by Countries
9.1 Middle East & Africa Parkinson’s Disease Treatments Revenue by Countries (2015-2020)
9.2 Saudi Arabia Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
9.3 UAE Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
9.4 Egypt Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
9.5 South Africa Parkinson’s Disease Treatments Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Parkinson’s Disease Treatments Revenue and Market Share by Type (2015-2020)
10.2 Global Parkinson’s Disease Treatments Market Forecast by Type (2019-2024)
10.3 Dopamine Agonists Revenue Growth Rate (2015-2025)
10.4 Levodopa Revenue Growth Rate (2015-2025)
10.5 Glutamate Antagonist Revenue Growth Rate (2015-2025)
10.6 Apomorphine Revenue Growth Rate (2015-2025)
10.7 COMT Inhibitors Anticholinergics Revenue Growth Rate (2015-2025)
10.8 MAO-B Inhibitors Revenue Growth Rate (2015-2025)
10.9 Other Drugs Revenue Growth Rate (2015-2025)
11 Global Parkinson’s Disease Treatments Market Segment by Application
11.1 Global Parkinson’s Disease Treatments Revenue Market Share by Application (2015-2020)
11.2 Parkinson’s Disease Treatments Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Healthcare Institutes Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Parkinson’s Disease Treatments Market Size Forecast (2021-2025)
12.1 Global Parkinson’s Disease Treatments Market Size Forecast (2021-2025)
12.2 Global Parkinson’s Disease Treatments Market Forecast by Regions (2021-2025)
12.3 North America Parkinson’s Disease Treatments Revenue Market Forecast (2021-2025)
12.4 Europe Parkinson’s Disease Treatments Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Parkinson’s Disease Treatments Revenue Market Forecast (2021-2025)
12.6 South America Parkinson’s Disease Treatments Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Parkinson’s Disease Treatments Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Parkinson's Disease Treatments Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Parkinson's Disease Treatments by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Parkinson's Disease Treatments Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Parkinson's Disease Treatments Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GSK Corporate Information, Location and Competitors
Table 6. GSK Parkinson's Disease Treatments Major Business
Table 7. GSK Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 8. GSK SWOT Analysis
Table 9. GSK Parkinson's Disease Treatments Product and Solutions
Table 10. GSK Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bausch Health Corporate Information, Location and Competitors
Table 12. Bausch Health Parkinson's Disease Treatments Major Business
Table 13. Bausch Health Parkinson's Disease Treatments Total Revenue (USD Million) (2018-2019)
Table 14. Bausch Health SWOT Analysis
Table 15. Bausch Health Parkinson's Disease Treatments Product and Solutions
Table 16. Bausch Health Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Teva Corporate Information, Location and Competitors
Table 18. Teva Parkinson's Disease Treatments Major Business
Table 19. Teva Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 20. Teva SWOT Analysis
Table 21. Teva Parkinson's Disease Treatments Product and Solutions
Table 22. Teva Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Parkinson's Disease Treatments Major Business
Table 25. Merck Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Parkinson's Disease Treatments Product and Solutions
Table 28. Merck Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Abbvie Corporate Information, Location and Competitors
Table 30. Abbvie Parkinson's Disease Treatments Major Business
Table 31. Abbvie Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 32. Abbvie SWOT Analysis
Table 33. Abbvie Parkinson's Disease Treatments Product and Solutions
Table 34. Abbvie Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Parkinson's Disease Treatments Major Business
Table 37. Novartis Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Parkinson's Disease Treatments Product and Solutions
Table 40. Novartis Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sun Pharma Corporate Information, Location and Competitors
Table 42. Sun Pharma Parkinson's Disease Treatments Major Business
Table 43. Sun Pharma Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 44. Sun Pharma SWOT Analysis
Table 45. Sun Pharma Parkinson's Disease Treatments Product and Solutions
Table 46. Sun Pharma Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Impax Corporate Information, Location and Competitors
Table 48. Impax Parkinson's Disease Treatments Major Business
Table 49. Impax Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 50. Impax SWOT Analysis
Table 51. Impax Parkinson's Disease Treatments Product and Solutions
Table 52. Impax Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 54. Boehringer Ingelheim Parkinson's Disease Treatments Major Business
Table 55. Boehringer Ingelheim Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 56. Boehringer Ingelheim SWOT Analysis
Table 57. Boehringer Ingelheim Parkinson's Disease Treatments Product and Solutions
Table 58. Boehringer Ingelheim Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Lundbeck Corporate Information, Location and Competitors
Table 60. Lundbeck Parkinson's Disease Treatments Major Business
Table 61. Lundbeck Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 62. Lundbeck SWOT Analysis
Table 63. Lundbeck Parkinson's Disease Treatments Product and Solutions
Table 64. Lundbeck Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Wockhardt Corporate Information, Location and Competitors
Table 66. Wockhardt Parkinson's Disease Treatments Major Business
Table 67. Wockhardt Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 68. Wockhardt SWOT Analysis
Table 69. Wockhardt Parkinson's Disease Treatments Product and Solutions
Table 70. Wockhardt Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Acadia Corporate Information, Location and Competitors
Table 72. Acadia Parkinson's Disease Treatments Major Business
Table 73. Acadia Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 74. Acadia SWOT Analysis
Table 75. Acadia Parkinson's Disease Treatments Product and Solutions
Table 76. Acadia Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. UCB Corporate Information, Location and Competitors
Table 78. UCB Parkinson's Disease Treatments Major Business
Table 79. UCB Parkinson's Disease Treatments Total Revenue (USD Million) (2017-2018)
Table 80. UCB SWOT Analysis
Table 81. UCB Parkinson's Disease Treatments Product and Solutions
Table 82. UCB Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Parkinson's Disease Treatments Revenue (Million USD) by Players (2015-2020)
Table 84. Global Parkinson's Disease Treatments Revenue Share by Players (2015-2020)
Table 85. Global Parkinson's Disease Treatments Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Parkinson's Disease Treatments Revenue Market Share by Regions (2015-2020)
Table 87. North America Parkinson's Disease Treatments Revenue by Countries (2015-2020)
Table 88. North America Parkinson's Disease Treatments Revenue Market Share by Countries (2015-2020)
Table 89. Europe Parkinson's Disease Treatments Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Parkinson's Disease Treatments Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Parkinson's Disease Treatments Revenue by Countries (2015-2020)
Table 92. South America Parkinson's Disease Treatments Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Parkinson's Disease Treatments Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries (2015-2020)
Table 95. Global Parkinson's Disease Treatments Revenue (Million USD) by Type (2015-2020)
Table 96. Global Parkinson's Disease Treatments Revenue Share by Type (2015-2020)
Table 97. Global Parkinson's Disease Treatments Revenue Forecast by Type (2021-2025)
Table 98. Global Parkinson's Disease Treatments Revenue by Application (2015-2020)
Table 99. Global Parkinson's Disease Treatments Revenue Share by Application (2015-2020)
Table 100. Global Parkinson's Disease Treatments Revenue Forecast by Application (2021-2025)
Table 101. Global Parkinson's Disease Treatments Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Parkinson's Disease Treatments Picture
Figure 2. Global Parkinson's Disease Treatments Revenue Market Share by Type in 2019
Figure 3. Dopamine Agonists Picture
Figure 4. Levodopa Picture
Figure 5. Glutamate Antagonist Picture
Figure 6. Apomorphine Picture
Figure 7. COMT Inhibitors Anticholinergics Picture
Figure 8. MAO-B Inhibitors Picture
Figure 9. Other Drugs Picture
Figure 10. Parkinson's Disease Treatments Revenue Market Share by Application in 2019
Figure 11. Hospitals Picture
Figure 12. Healthcare Institutes Picture
Figure 13. Others Picture
Figure 14. Global Parkinson's Disease Treatments Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Parkinson's Disease Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Parkinson's Disease Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Parkinson's Disease Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Parkinson's Disease Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Parkinson's Disease Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Parkinson's Disease Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Parkinson's Disease Treatments Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Parkinson's Disease Treatments Revenue Market Share in 2019
Figure 23. Global Top 10 Players Parkinson's Disease Treatments Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Parkinson's Disease Treatments Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Parkinson's Disease Treatments Revenue Market Share by Regions (2015-2020)
Figure 27. Global Parkinson's Disease Treatments Revenue Market Share by Regions in 2018
Figure 28. North America Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 29. Europe Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 31. South America Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 33. North America Parkinson's Disease Treatments Revenue Market Share by Countries (2015-2020)
Figure 34. North America Parkinson's Disease Treatments Revenue Market Share by Countries in 2019
Figure 35. USA Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 36. Canada Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 38. Europe Parkinson's Disease Treatments Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Parkinson's Disease Treatments Revenue Market Share by Countries in 2019
Figure 40. Germany Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 41. UK Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 42. France Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 43. Russia Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 44. Italy Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Parkinson's Disease Treatments Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Parkinson's Disease Treatments Revenue Market Share by Countries in 2019
Figure 47. China Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 48. Japan Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 49. Korea Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 50. India Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 52. South America Parkinson's Disease Treatments Revenue Market Share by Countries (2015-2020)
Figure 53. South America Parkinson's Disease Treatments Revenue Market Share by Countries in 2019
Figure 54. Brazil Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 59. UAE Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
Figure 62. Global Parkinson's Disease Treatments Revenue Share by Type (2015-2020)
Figure 63. Global Parkinson's Disease Treatments Revenue Share by Type in 2019
Figure 64. Global Parkinson's Disease Treatments Market Share Forecast by Type (2021-2025)
Figure 65. Global Dopamine Agonists Revenue Growth Rate (2015-2020)
Figure 66. Global Levodopa Revenue Growth Rate (2015-2020)
Figure 67. Global Glutamate Antagonist Revenue Growth Rate (2015-2020)
Figure 68. Global Apomorphine Revenue Growth Rate (2015-2020)
Figure 69. Global COMT Inhibitors Anticholinergics Revenue Growth Rate (2015-2020)
Figure 70. Global MAO-B Inhibitors Revenue Growth Rate (2015-2020)
Figure 71. Global Other Drugs Revenue Growth Rate (2015-2020)
Figure 72. Global Parkinson's Disease Treatments Revenue Share by Application (2015-2020)
Figure 73. Global Parkinson's Disease Treatments Revenue Share by Application in 2019
Figure 74. Global Parkinson's Disease Treatments Market Share Forecast by Application (2021-2025)
Figure 75. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 76. Global Healthcare Institutes Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Parkinson's Disease Treatments Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Parkinson's Disease Treatments Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Parkinson's Disease Treatments Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
Figure 82. Europe Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
Figure 84. South America Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
パーキンソン病治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Parkinson's Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Parkinson's Disease …- 歯内治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Endodontics Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Endodontics Treatments…
- ウルフパーキンソンホワイト症候群治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Wolff Parkinson White Syndrome Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wolf…
- クラッベ病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Krabbe Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Krabbe Disease Treat…
- 胃食道逆流症（GERD）治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4989.6 million by 2025, from USD 4870.2 milli…